1.905
price down icon3.61%   -0.075
 
loading
Longeveron Inc stock is traded at $1.905, with a volume of 610.32K. It is down -3.61% in the last 24 hours and down -12.85% over the past month. Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$1.98
Open:
$2
24h Volume:
610.32K
Relative Volume:
1.05
Market Cap:
$27.15M
Revenue:
$709.00K
Net Income/Loss:
$-21.41M
P/E Ratio:
-2.0053
EPS:
-0.95
Net Cash Flow:
$-19.70M
1W Performance:
-12.05%
1M Performance:
-12.85%
6M Performance:
+49.10%
1Y Performance:
-89.96%
1-Day Range:
Value
$1.88
$2.06
1-Week Range:
Value
$1.85
$2.31
52-Week Range:
Value
$0.7707
$23.90

Longeveron Inc Stock (LGVN) Company Profile

Name
Name
Longeveron Inc
Name
Phone
305-302-7158
Name
Address
1951 NW 7TH AVENUE, MIAMI
Name
Employee
24
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
LGVN's Discussions on Twitter

Compare LGVN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LGVN 1.905 27.15M 709.00K -21.41M -19.70M -0.95
VRTX 467.14 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.26 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 565.93 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.62 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.14 24.08B 3.30B -501.07M 1.03B 11.54

Longeveron Inc Stock (LGVN) Latest News

pulisher
Nov 15, 2024

We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Longeveron Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

The Escalator: Sanofi, Longeveron, Geron and more - MM+M Online

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings call: Longeveron Q3 2024 results show promise in regenerative medicine - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Longeveron Inc. (NASDAQ:LGVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 12, 2024

Longeveron reports Q3 EPS (34c), consensus (44c) - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

LGVNLongeveron Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

A Look Ahead: Longeveron's Earnings Forecast - Benzinga

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron names Devin Blass as new CTO - Investing.com

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron names Devin Blass as new CTO By Investing.com - Investing.com UK

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron Taps Devin Blass As CTO And SVP Of CMC - Contract Pharma

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron Taps Devin Blass As CTO And SVP Of Chemistry, Manufacturing And Controls - Contract Pharma

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC) - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Longeveron Strengthens Leadership: Key Executive Hire Ahead of Critical BLA Submission | LGVN Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2024 Result - Yahoo Finance

Nov 11, 2024
pulisher
Nov 05, 2024

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - StockTitan

Nov 05, 2024
pulisher
Nov 04, 2024

Peeling Back The Layers: Exploring Longeveron Through Analyst Insights - Benzinga

Nov 04, 2024
pulisher
Oct 30, 2024

Longeveron presents Alzheimer's therapy data at CTAD24 - Investing.com

Oct 30, 2024
pulisher
Oct 29, 2024

Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Longeveron presents Alzheimer's therapy data at CTAD24 By Investing.com - Investing.com UK

Oct 29, 2024
pulisher
Oct 29, 2024

Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - StockTitan

Oct 29, 2024
pulisher
Oct 27, 2024

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - ForexTV.com

Oct 27, 2024
pulisher
Oct 27, 2024

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire Inc.

Oct 27, 2024
pulisher
Oct 27, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Oct 27, 2024
pulisher
Oct 25, 2024

Why has Longeveron stock tripled in two days? - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Euro FX (E6N18) Quote - The Globe and Mail

Oct 24, 2024
pulisher
Oct 23, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 23, 2024

Scholastic Corp (SCHL-Q) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 15, 2024

LGVN’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

LGVNRLongeveron Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - ForexTV.com

Oct 14, 2024
pulisher
Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times

Oct 14, 2024
pulisher
Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected - GlobeNewswire

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Invests $236,000 in Longeveron Inc. (NASDAQ:LGVN) - Defense World

Oct 13, 2024
pulisher
Oct 09, 2024

Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire

Oct 09, 2024
pulisher
Oct 08, 2024

Longeveron to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - Marketscreener.com

Oct 08, 2024
pulisher
Oct 07, 2024

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - The Manila Times

Oct 07, 2024
pulisher
Oct 03, 2024

Longeveron to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Marketscreener.com

Oct 03, 2024
pulisher
Oct 02, 2024

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - The Manila Times

Oct 02, 2024
pulisher
Sep 28, 2024

BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa - MSN

Sep 28, 2024
pulisher
Sep 26, 2024

Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - The Manila Times

Sep 26, 2024
pulisher
Sep 26, 2024

Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa - StockTitan

Sep 26, 2024
pulisher
Sep 24, 2024

Lamb Weston (LW) Scheduled to Post Quarterly Earnings on Tuesday - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Analysts review Longeveron Inc’s rating - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Lamb Weston (NYSE:LW) Price Target Raised to $75.00 - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Ratios Reveal: Breaking Down Longeveron Inc (LGVN)’s Financial Health - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

In the Green: Longboard Pharmaceuticals Inc (LBPH) Closes at 33.89, Up/Down 1.47 from Previous Day - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Was there any good news for Longeveron Inc (LGVN) stock in the last session? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Was Longboard Pharmaceuticals Inc (LBPH)’s session last reading good? - US Post News

Sep 23, 2024

Longeveron Inc Stock (LGVN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Longeveron Inc Stock (LGVN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Hare Joshua
Chief Scientific Officer
Apr 11 '24
Buy
2.35
42,553
100,000
633,280
Hashad Mohamed Wa'el Ahmed
Chief Executive Officer
Apr 11 '24
Buy
2.35
10,638
24,999
19,616
Soffer Rock
Director
Apr 10 '24
Buy
2.35
106,383
250,000
176,619
Soffer Rock
Director
Apr 11 '24
Buy
2.35
31,915
75,000
208,534
Ross Cathy
Director
Jan 10 '24
Buy
1.31
5,000
6,544
10,000
Baluch Khoso
Director
Dec 29 '23
Buy
1.43
8,322
11,915
15,000
Baluch Khoso
Director
Dec 28 '23
Buy
1.40
1,678
2,342
6,678
PFEFFER JEFFREY
Director
Dec 28 '23
Buy
1.35
10,000
13,500
15,000
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.04
price down icon 0.87%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):